On May 29, Astera Labs fell 3.08% in regular trading, trading at $339.17/share, with trading volume of approximately $319 million.

On the news front, Northland Capital Markets previously downgraded Astera Labs from Outperform to Market Perform, citing elevated valuation and growing concerns that hyperscale cloud providers may cut AI infrastructure spending in 2027. According to FactSet data, the stock's average analyst price target stands at $246.01, significantly below the current trading level. Additionally, the company's President and COO recently sold approximately 399,000 shares, while a trust associated with a former executive filed plans to sell another 30,000 shares worth roughly $10.4 million, reinforcing market concerns over stretched valuations.

Although the stock previously benefited from Anthropic's $100 billion compute agreement with AWS — with JPMorgan noting Astera Labs supplies switching and signal conditioning products for AWS Trainium chips — the combined weight of the analyst downgrade and insider selling continues to cap upside momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)